Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Oct;63(7):2391-2405.
doi: 10.1007/s00394-024-03455-2. Epub 2024 Jul 5.

Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials

Ângela C Bersch-Ferreira  1   2 , Elana Stein  3 , Gustavo Waclawovsky  3 , Lucas R da Silva  1 , Rachel H V Machado  4 , Camila Weschenfelder  3 , Mabel F Figueiro  1 , Erica A Suzumura  5 , Renato H N Santos  4 , Graziela Biude Silva Duarte  6 , Marcelo M Rogero  6 , Erlon O de Abreu-Silva  4   7 , Alexandre B Cavalcanti  4 , Aline Marcadenti  8   9   10
Affiliations
Meta-Analysis

Effect of nuts on lipid profile and inflammatory biomarkers in atherosclerotic cardiovascular disease: a systematic review and meta-analysis of randomized controlled trials

Ângela C Bersch-Ferreira et al. Eur J Nutr. 2024 Oct.

Abstract

Purpose: Nut-enriched diets are related to improve lipid and inflammatory biomarkers in meta-analyses in the context of primary cardiovascular prevention. However, primary studies on secondary cardiovascular prevention are scarce and controversial. This systematic review and meta-analysis aimed to evaluate the effect of nut supplementation on lipid and inflammatory profiles in individuals with atherosclerotic cardiovascular disease, and the frequency of adverse events.

Methods: Six databases were used for research: PubMed, EMBASE, BVS, Cochrane Library, Web of Science, and ClinicalTrials.gov, until February 2023, with no language restrictions. We performed random-effects meta-analyses to compare nut-enriched diets vs. control diets for pre-post intervention changes. The Grading of Recommendations Assessment, Development and Evaluation (GRADE) system assessed the evidence's certainty.

Results: From the 5187 records identified, eight publications containing data referring to five randomized clinical trials involving 439 participants were included in the final analyses. The nuts evaluated were almonds, pecans, Brazil nuts, and mixed nuts, with doses ranging between 5 g and 85 g (median: 30 g/day). The intervention time varied between 6 and 12 weeks. Compared to nut-free diets, nut intake did not have a statistically significant effect on lipid profile biomarkers, except on the atherogenic index (MD: -0.32 [95% CI -0.58 to -0.06], I2 = 0% - moderate certainty of the evidence). Similarly, there was no effect of nuts on inflammatory profile biomarkers. It was not possible to aggregate data on adverse events.

Conclusions: Nut supplementation did not change lipid and inflammatory profiles in the secondary cardiovascular prevention setting.

Keywords: Cholesterol, LDL; Inflammation; Meta-analysis; Nuts; Secondary prevention.

PubMed Disclaimer

References

    1. Vaduganathan M, Mensah GA, Turco JV, Fuster V, Roth GA (2022) The Global Burden of Cardiovascular diseases and Risk: a compass for Future Health. J Am Coll Cardiol 80:2361–2371. https://doi.org/10.1016/j.jacc.2022.11.005 - DOI - PubMed
    1. Roth GA, Mensah GA, Johnson CO et al (2020) Global Burden of Cardiovascular diseases and Risk factors, 1990–2019: Update from the GBD 2019 study. J Am Coll Cardiol 76:2982–3021. https://doi.org/10.1016/j.jacc.2020.11.010 - DOI - PubMed - PMC
    1. Borén J, Chapman MJ, Krauss RM et al (2020) Low-density lipoproteins cause atherosclerotic cardiovascular disease: pathophysiological, genetic, and therapeutic insights: a consensus statement from the European Atherosclerosis Society Consensus Panel. Eur Heart J 41:2313–2330. https://doi.org/10.1093/eurheartj/ehz962 - DOI - PubMed - PMC
    1. Peng X, Wu H (2022) Inflammatory links between hypertriglyceridemia and Atherogenesis. Curr Atheroscler Rep 24:297–306. https://doi.org/10.1007/s11883-022-01006-w - DOI - PubMed - PMC
    1. Hartman J, Frishman WH (2014) Inflammation and atherosclerosis: a review of the role of interleukin-6 in the development of atherosclerosis and the potential for targeted drug therapy. Cardiol Rev 22:147–151. https://doi.org/10.1097/CRD.0000000000000021 - DOI - PubMed

Grants and funding

LinkOut - more resources